Back to search

Article

CRISPR-Cas9 genome engineering as a novel prognostic tools for Prostate cancer: long non-coding RNAs the predictive diagnostic index of targeted liposomal-coated compounds in prostate cancer therapy

2022-05-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>CRISPR/Cas9 is a recently explored genomic editing system that has greatly altered the technique that scientists study genes and their functions in mammalian systems. Cas9 is regulated via guide RNAs that match the targeted DNA in cleavage to modify the respective gene. The incessant advancement in prostate cancer (PC) modeling has directed not only to innovate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8d11a6c-413b-57b7-b903-f05eb299e565
DOI
10.21203/rs.3.rs-1541397/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-Cas9 genome engineering as a novel prognostic tools for Prostate cancer: long non-coding RNAs the predictive diagnostic index of targeted liposomal-coated compounds in prostate cancer therapyDOI 10.21203/rs.3.rs-1541397/v1
Select a neighboring publication to make it the new centre.